A 26-year-old man visited our clinic because of a persistent cough. Although his chest roentgenography showed no abnormalities, a sputum culture revealed a positive result for Mycobacterium tuberculosis. Computed tomography (CT) prior to antituberculous chemotherapy demonstrated an esophagomediastinal fistula with subcarinal lymphadenopathy. One week after the treatment, he complained of a severe cough exacerbated by swallowing liquid. The development of a bronchoesophageal fistula (BEF) was suggested by esophagoscopy, and was confirmed by CT and bronchoscopy. The present case was unique because the process of BEF development could be followed by CT, and the BEF developed in an immunocompetent patient with relatively mild pulmonary tuberculosis.
Introduction
A bronchoesophageal fistula (BEF) is an unusual manifestation of tuberculosis and its correct diagnosis may sometimes be difficult because of an insidious and nonspecific clinical course (1) (2) (3) . When tuberculous lymph nodes erode the adjacent esophageal or bronchial wall, an esophagomediastinal fistula, bronchomediastinal fistula or BEF may be formed (2, 4) . Although BEFs and esophagomediastinal fistulas are usually diagnosed by esophagography, Im et al. demonstrated an esophagomediastinal fistula on thoracic computed tomography (CT) in four patients with tuberculous mediastinal lymphadenitis (3) . We herein present the case of a patient with pulmonary tuberculosis complicated with BEF in whom the process of the development of an esophagomediastinal fistula to a BEF was observed on a pair of CTs taken at an interval of 12 days.
Case Report
A 26-year-old Indonesian man visited an outpatient clinic of our hospital with a three-week history of a productive cough and a five kilogram weight loss over several months, but no remarkable previous clinical history. A physical examination and chest roentgenography showed no definite abnormality (Fig. 1A) . The laboratory data, including tumor markers and a serological test for human immunodeficiency virus (HIV) were within the normal ranges, except for a low level of hemoglobin (10.7 g/dL) and an elevated level of Creactive protein (6.24 mg/dL) ( Table 1) . His symptoms were not relieved by antitussive medication. Two weeks after the initial visit, a sputum culture and subsequent polymerase chain reaction revealed positive results for Mycobacterium tuberculosis, although a direct smear test for acid-fast bacilli was negative. A thoracic CT demonstrated a tree-in-bud appearance in the right upper and lower lobes and subcarinal mediastinal lymphadenopathy 1.5 cm in diameter containing a small cavity communicating with the esophageal lumen (Fig. 1B, C) . The patient was diagnosed to have pulmonary tuberculosis with an esophagomediastinal fistula.
Antituberculous treatment with rifampicin (RFP, 450 mg, once a day), isoniazid (INH, 300 mg, once a day), ethambutol (EB, 250 mg, three times a day) and pyrazinamide (PZA, 1,200 mg, once a day) was initiated. The tubercles bacilli isolated in this case were sensitive to all tested antituberculous agents including RFP, INH, EB and PZA. One week after the treatment was initiated, the patient com- 
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plained of a severe cough exacerbated by swallowing liquid, but not solid food. Gastroesophageal endoscopy demonstrated a small ulcerated lesion 3 mm in diameter located 25 cm from the upper incisor, and air bubbling was seen through it upon coughing, thus suggesting the existence of a BEF ( Fig. 2A) . A thoracic CT scan revealed subcarinal lymphadenopathy with fistula formation into the adjoining left main bronchus (Fig. 1D ). An orifice of the BEF was also confirmed at the membranous portion of the left main bronchus by a bronchoscopic examination (Fig. 2B) . Following a diagnosis of BEF, he was instructed to take water thickened with starch for relief of his cough after swallowing because he refused nasogastric tube feeding. His symptoms disappeared two weeks after the diagnosis of BEF while he continued taking the antituberculous chemotherapy. Six months after the initiation of antituberculous treatment, esophageal endoscopy showed a granulomatous lesion at the site of the BEF and a histological examination of the biopsy specimen revealed granuloma with positive Ziehl-Nielsen staining (Fig. 2C ). RFP and INH were continued for another six months, and complete closure of the BEF was confirmed by esophageal endoscopy (Fig. 2D) . 

Discussion
Most BEFs in adults result from a locally advanced esophageal or bronchogenic malignancy, and benign causes were found to be responsible for only 5-6% of such cases (5, 6) . Although a BEF is an unusual manifestation of tuberculosis, several studies have reported that mediastinal granulomatous inflammation caused by tuberculosis could account for 14-67% of benign BEFs, depending on the prevalence of tuberculosis in the study population (1, 2, 6, 7) . Recently, an increasing number of patients with BEF have been reported among patients with HIV infections, probably due to the tendency for lymph node tuberculosis to occur in patients with HIV infection (8) . However, the development of a BEF secondary to tuberculosis in non-HIV patients has rarely been reported in the literature since the advent of effective antituberculous chemotherapy (1-4) .
The possible mechanisms of BEF development associated with tuberculosis include the rupture of caseonecrotic mediastinal lymph nodes into the esophagus and bronchus, erosion of a bronchial ulcer into the esophagus, ulcerative esophageal tuberculosis that perforates into the trachea or bronchus and the development of traction diverticula between the respiratory tree and the esophagus (1-4) . The most unique feature of our case is that the process of BEF development was clearly demonstrated by a pair of thoracic CT scans taken at an interval of 12 days. Our case seemed to have emerged as tuberculous mediastinal lymphadenitis following the primary pulmonary infection. An esophagomediastinal fistula had developed at the subcarinal lymph node before the initiation of antituberculous treatment, and the node perforated into the left main bronchus soon after the initiation of treatment, which resulted in the BEF in the present case. There have been several reports that demonstrated an esophagomediastinal fistula or BEF on thoracic CT in separate cases; however, observing the process of BEF development in the same patient seem to be very rare and valuable (3, 8, 9) .
A second key feature is that our case suggested that a BEF can develop in patients with relatively mild pulmonary tuberculosis with solitary mediastinal lymphadenopathy, although the previously reported cases with tuberculous BEFs usually developed in patients with severe pulmonary tuberculosis, disseminated tuberculosis with extensive mediastinal lymphadenopathy or in immunocompromised patients with the pathological condition such as an HIV infection (3, 8, 10) . The development of a BEF secondary to tuberculosis seems to be rare in immunocompetent patients in Japan and to our knowledge, only five cases have been previously reported in the literature (Table 2 ) (11) (12) (13) (14) .
Traditionally, surgical repair had been advocated for all benign BEFs, including those of tuberculous origin, because the results of non-surgical treatment had been unsatisfactory (2, 4, 15) . However, since the first case of successful treatment of a tuberculous BEF with medical management alone was reported in 1976, antituberculous chemotherapy has become the mainstay for the management of tuberculous BEFs, even in patients with HIV infection or multi-drugresistant tuberculous infections (1, 3, 8, 14) .
Recently, endoscopic repair of BEFs with fibrin glue or hemoclipping has been attempted; however, the outcomes appear to depend on the length and width of the fistula (6, 10). Although our patient was successfully treated by antituberculous chemotherapy alone, the effect of treatment for tuberculous BEFs are somewhat confusing (5-7). Patients with a BEF associated with tuberculosis may be classified into two groups according to the activity of tuberculosis and the degree of fistula tract maturation; patients with a BEF accompanied by active pulmonary tuberculosis and those with a BEF developing after cure of tuberculosis (6) . Most patients with immature BEFs developed with active tuberculosis respond well to antituberculous chemotherapy alone, although some cases may require strict nasogastric tube feeding or jejunostomy during medical treatment (1, 3, 8) . Since a BEF that develops after the cure of tuberculosis is usually related to well-epithelialized fistula tracts, such fistulas are likely to be difficult to cure by medical treatment (6) . In these cases, early surgical intervention is definitively indicated, although the surgery is usually invasive, and the in-hospital mortality rate has been reported to be as high as 15.4% (4, 5, 15) . Accordingly, several trials for endoscopic repair of BEF have been reported, but the success rate is still unsatisfactory (6) .
In conclusion, the combination of mediastinal lymphadenopathy and intractable cough should alert clinicians treating patients with tuberculosis to the possibility of a developing BEF, even if the patient's disease appears to be mild. Thoracic CT is useful for detecting a BEF or esophagomediastinal fistula, and antituberculous chemotherapy alone may be sufficient for the management of such patients.
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